RecruitingNot ApplicableNCT03347227

Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation

Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (Coast-AF) Randomized Clinical Trial


Sponsor

Ottawa Heart Institute Research Corporation

Enrollment

502 participants

Start Date

Aug 24, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

A multicentre, parallel group, two arm, single-blinded randomized clinical trial, assessing the efficacy of a patient-tailored catheter ablation (CA) strategy guided by atrial scar mapping in addition to pulmonary vein isolation (PVI) when compared to PVI alone in patients with persistent atrial fibrillation (AF).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying a new approach to treating a type of long-lasting irregular heartbeat (called persistent atrial fibrillation) by mapping and targeting the specific areas of the heart causing the problem before performing a procedure to correct it. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with persistent atrial fibrillation (an irregular heartbeat lasting more than 3 months) that is causing symptoms - Your doctor has recommended a catheter ablation procedure (a minimally invasive heart procedure) to treat your irregular heartbeat - You have had at least one episode of this irregular heartbeat documented on a heart monitor within the last 3 years - You have a certain risk score (Modified DR-FLASH score of 4 or higher) - You are able to give your informed consent **You may NOT be eligible if...** - You have previously had a catheter ablation procedure for atrial fibrillation - You do not meet the required risk score threshold Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURECatheter ablation

Wide area circumferential catheter ablation for pulmonary vein isolation of persistent atrial fibrillation


Locations(15)

Libin Cardiovascular Institute

Calgary, Alberta, Canada

Vancouver General Hospital

Vancouver, British Columbia, Canada

QEII Health Sciences Centre, Nova Scotia Health Authority

Halifax, Nova Scotia, Canada

Hamilton General Hospital

Hamilton, Ontario, Canada

London Health Sciences Centre

London, Ontario, Canada

Southlake Regional Health Centre

Newmarket, Ontario, Canada

University of Ottawa Heart Institute

Ottawa, Ontario, Canada

St. Michael's Hospital

Toronto, Ontario, Canada

Rouge Valley Regional Heart Centre

Toronto, Ontario, Canada

Centre Hospitalier de l'Universite de Montreal (CHUM)

Montreal, Quebec, Canada

Sacre-Coeur Hospital

Montreal, Quebec, Canada

McGill University Health Centre

Montreal, Quebec, Canada

Montreal Heart Institute

Montreal, Quebec, Canada

Institute Universitaire de Cardiologie et Pneumologie du Quebec (IUCPQ)

Québec, Quebec, Canada

CIUSSS de L'Estrie-CHUS-Hopital Fleurimont

Sherbrooke, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03347227


Related Trials